Jubilee Post News & Views
Special Desk
While US remains a hotspot of the world amid the surging COVID-19 cases, the US President Donald Trump has said that his administration will announce good news regarding therapeutics developed for the infection in next two weeks.
Trump who has to face elections in November said, “With respect to therapeutics, I can tell you that I think over the next couple of weeks, we will have some really, very good things to say.”
Trump’s comment came on the day the world’s biggest COVID-19 vaccine study got underway with the first of 30,000 planned volunteers helping to test shots created by the US government — one of several candidates in the final stretch of the global vaccine race.
Vaccine trials are going on in several countries including India where vaccines under trials have been administered to the humans and the results are awaiting in the next few weeks. But Trump’s announcement has made the world think upon a solution to the virus. It may be coming soon.
Also Read : North Korea on alert over ‘first suspected coronavirus case’
Also Read : COVID-19: Is it trade gameplan?
The trial of the vaccine, developed by the National Institutes of Health and Moderna Inc, is one of the first late-stage studies supported by the Trump administration’s effort to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.
Moderna, which has never brought a vaccine to market, has received nearly $1 billion from the US government, which is helping bankroll several vaccine candidates under its Operation Warp Speed program.
More than 6.53 lakh people have died of COVID-19 globally and over 1.64 crore tested positive for the disease. In the US alone, more than 1.48 lakh Americans have died and nearly 43 lakh people tested positive for the novel coronavirus, according to Johns Hopkins University data.
